Cambodia: Cambodia Rapid Immunization Support Project under the Asia Pacific Vaccine Access Facility

Sovereign Project | 55104-001

The project is aligned with the following impacts: (i) severity of the pandemic reduced, lives saved, and social disruptions minimized; and (ii) negative health, social, and economic effects of the COVID-19 pandemic mitigated. The project will have the following outcome: about 10.12 million people in target populations vaccinated or boosted against COVID-19.

The project will support the procurement of an estimated 14.5 million doses of safe and effective COVID-19 vaccines via the APVAX rapid response component (RRC) and the AIIB loan. It will contribute to the government's goal of strengthening population immunity by providing booster doses and primary vaccination to children below 5. The project will also help to develop and disseminate social and gender-inclusive guidelines to ensure equitable coverage of COVID-19 vaccination

Project Details

  • Project Officer
    Elfving, Rikard N.
    Southeast Asia Department
    Request for information
  • Approval Date
    15 February 2022
  • Country/Economy
    Cambodia
  • Sector
    • Health
Project Name Cambodia Rapid Immunization Support Project under the Asia Pacific Vaccine Access Facility
Project Number 55104-001
Country / Economy Cambodia
Project Status Approved
Project Type / Modality of Assistance Loan
Source of Funding / Amount
Loan 4173-CAM: Cambodia Rapid Immunization Support Project under the Asia Pacific Vaccine Access Facility
Concessional ordinary capital resources lending US$ 95.00 million
Loan 8416-CAM: Cambodia Rapid Immunization Support Project under the Asia Pacific Vaccine Access Facility
Asian Infrastructure Investment Bank US$ 50.00 million
Strategic Agendas Inclusive economic growth
Regional integration
Drivers of Change Gender Equity and Mainstreaming
Knowledge solutions
Partnerships
Sector / Subsector

Health / Disease control of communicable disease

Gender Equity and Mainstreaming Effective gender mainstreaming
Description

The project is aligned with the following impacts: (i) severity of the pandemic reduced, lives saved, and social disruptions minimized; and (ii) negative health, social, and economic effects of the COVID-19 pandemic mitigated. The project will have the following outcome: about 10.12 million people in target populations vaccinated or boosted against COVID-19.

The project will support the procurement of an estimated 14.5 million doses of safe and effective COVID-19 vaccines via the APVAX rapid response component (RRC) and the AIIB loan. It will contribute to the government's goal of strengthening population immunity by providing booster doses and primary vaccination to children below 5. The project will also help to develop and disseminate social and gender-inclusive guidelines to ensure equitable coverage of COVID-19 vaccination

Project Rationale and Linkage to Country/Regional Strategy Cambodia was largely successful in controlling coronavirus disease (COVID-19) in 2020. An outbreak in February of 2021, however, led to widespread closures of schools and business and a lockdown in Phnom Penh and other heavily impacted areas until the fourth quarter of 2021. As of 3 January 2022, Cambodia had 120,516 confirmed COVID-19 cases and 3,014 deaths. Cambodia launched its vaccination campaign on 10 February 2021 and has administered over 28 million doses, covering over 80% of its total population of 16.7 million. It has also provided booster doses to 21.8% of its population. Despite the country's success in rolling-out COVID-19 vaccination, its health system remains highly vulnerable to a surge in new infections linked to variants such as Delta and Omicron.
Impact

Severity of the pandemic reduced, lives saved, and social disruptions minimized

Negative health, social, and economic effects of the COVID-19 pandemic mitigated

Project Outcome
Description of Outcome Target populations vaccinated or boosted against COVID-19
Progress Toward Outcome
Implementation Progress
Description of Project Outputs COVID-19 vaccines deployed
Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide
Safeguard Categories
Environment C
Involuntary Resettlement C
Indigenous Peoples C
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation
Business Opportunities
Procurement Procurement will be undertaken with simplified and expedient procedures permitted under the ADB Procurement Policy (2017, as amended from time to time) and Procurement Regulations for ADB Borrowers (2017, as amended from time to time).
Responsible ADB Officer Elfving, Rikard N.
Responsible ADB Department Southeast Asia Department
Responsible ADB Division Human and Social Development Division, SERD
Executing Agencies
Ministry of Health
Dr. Mam Bun Heng
No. 151-153, Avenue Kampuchea Krom
1537 Phnom Penh
Kingdom of Cambodia
Timetable
Concept Clearance -
Fact Finding 29 Mar 2021 to 02 Apr 2021
MRM 28 May 2021
Approval 15 Feb 2022
Last Review Mission -
Last PDS Update 15 Feb 2022

Loan 4173-CAM

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
15 Feb 2022 - - 31 Dec 2024 - -
Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 103.50 Cumulative Contract Awards
ADB 95.00 01 Apr 2022 0.00 0.00 0%
Counterpart 8.50 Cumulative Disbursements
Cofinancing 0.00 01 Apr 2022 0.00 0.00 0%

Loan 8416-CAM

Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 50.00 Cumulative Contract Awards
ADB 0.00 - 0.00 0.00 %
Counterpart 0.00 Cumulative Disbursements
Cofinancing 50.00 - 0.00 0.00 %

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.


Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.


Evaluation Documents See also: Independent Evaluation

None currently available.


Related Publications

None currently available.


The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

No tenders for this project were found.


Contracts Awarded

No contracts awarded for this project were found